PMDA drug package insert
トレリーフOD錠25mg
PMDA Prescription drug · 住友ファーマ株式会社 · package insert Sep 28, 2023
Key facts
| Brand names | トレリーフOD錠25mg, トレリーフOD錠50mg |
|---|---|
| Nonproprietary names | ゾニサミド |
| Companies | 製造販売元／住友ファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | パーキンソン病治療薬・レビー小体型認知症に伴うパーキンソニズム治療薬（レボドパ賦活剤）（OD錠25mg）; パーキンソン病治療薬（レボドパ賦活剤）（OD錠50mg） |
| Therapeutic category codes | 871169 |
| YJ codes | 1169015F2022, 1169015F3029 |
| Approval numbers | 22600AMX00957, 22900AMX00642 |
| Package insert edition | 第2版、再審査結果 |
| Package insert date | Sep 28, 2023 |
| PMDA document key | 400093_1169015F2022_1 |
| PMDA company code | 400093 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: